NUFLENZYX Trademark

Trademark Overview

On Thursday, June 24, 2021, a trademark application was filed for NUFLENZYX with the United States Patent and Trademark Office. The USPTO has given the NUFLENZYX trademark a serial number of 90793181. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 16, 2024. This trademark is owned by Novavax, Inc.. The NUFLENZYX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the field of vaccines, and clinical trials and post-market trials related to vaccines; consulting services in the field of research and development of vaccines; vaccine research and development
nuflenzyx

General Information

Serial Number90793181
Word MarkNUFLENZYX
Filing DateThursday, June 24, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 21, 2021

Trademark Statements

Goods and ServicesProviding medical and scientific research information in the field of vaccines, and clinical trials and post-market trials related to vaccines; consulting services in the field of research and development of vaccines; vaccine research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 8, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovavax, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878
Party NameNovavax, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878

Trademark Events

Event DateEvent Description
Monday, June 28, 2021NEW APPLICATION ENTERED
Thursday, November 18, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 1, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 21, 2021PUBLISHED FOR OPPOSITION
Tuesday, December 21, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, September 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 17, 2021ASSIGNED TO EXAMINER
Tuesday, February 15, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 25, 2022SOU TEAS EXTENSION RECEIVED
Monday, July 25, 2022SOU EXTENSION 1 FILED
Monday, July 25, 2022SOU EXTENSION 1 GRANTED
Wednesday, July 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 29, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 29, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 29, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 29, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 29, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 9, 2022SOU TEAS EXTENSION RECEIVED
Friday, December 9, 2022SOU EXTENSION 2 FILED
Friday, December 9, 2022SOU EXTENSION 2 GRANTED
Tuesday, December 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 13, 2023SOU TEAS EXTENSION RECEIVED
Saturday, April 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 27, 2023SOU TEAS EXTENSION RECEIVED
Monday, November 27, 2023SOU EXTENSION 4 GRANTED
Thursday, April 13, 2023SOU EXTENSION 3 FILED
Thursday, April 13, 2023SOU EXTENSION 3 GRANTED
Monday, November 27, 2023SOU EXTENSION 4 FILED
Wednesday, November 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 4, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 16, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, September 16, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 4, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 4, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

nuflenzyx vaccines research field development trials related consulting services vaccine market